Protara Therapeutics, Inc.: Q3 2025 results
Published 10. 11. 2025, before the market opens. EPS -0,31 $ against an estimate of -0,39.
AI summary
AIThe summary shows how the results turned out, what the company delivered, the pros and cons and why the stock reacted the way it did. We do not have a press release for this quarter yet, so the summary would be based on the numbers alone.